Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
Abstract
Objective:
Methods:
Results:
Conclusions:
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
REFERENCES
Information & Authors
Information
Published In
Copyright
Publication History
Disclosure
Study Funding
Authors
Author Contributions
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Cognitive Impairment in People Living with HIV and the Impact of Mood: Results from a Cross-Sectional Study, Journal of Clinical Medicine, 13, 6, (1631), (2024).https://doi.org/10.3390/jcm13061631
- Antiretroviral drugs from multiple classes induce loss of excitatory synapses between hippocampal neurons in culture, Frontiers in Pharmacology, 15, (2024).https://doi.org/10.3389/fphar.2024.1369757
- HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis, Frontiers in Microbiology, 15, (2024).https://doi.org/10.3389/fmicb.2024.1428239
- Neurological Complications Caused by Human Immunodeficiency Virus (HIV) and Associated Opportunistic Co-infections: A Review on their Diagnosis and Therapeutic Insights, CNS & Neurological Disorders - Drug Targets, 23, 3, (284-305), (2024).https://doi.org/10.2174/1871527322666230330083708
- The prevalence of major depressive disorder in people with HIV : Results from the All of Us Research Program , HIV Medicine, 25, 8, (998-1004), (2024).https://doi.org/10.1111/hiv.13653
- Short‐term exposure to HIV Tat induces glial activation and changes in perineuronal nets, European Journal of Neuroscience, 60, 3, (4303-4316), (2024).https://doi.org/10.1111/ejn.16427
- Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical Trial, JAIDS Journal of Acquired Immune Deficiency Syndromes, 97, 2, (180-191), (2024).https://doi.org/10.1097/QAI.0000000000003480
- Medical comorbidities and lower myelin content are associated with poor cognition in young adults with perinatally acquired HIV, AIDS, 38, 14, (1932-1939), (2024).https://doi.org/10.1097/QAD.0000000000003989
- Association between tight junction proteins and cognitive performance in untreated persons with HIV, AIDS, 38, 9, (1292-1303), (2024).https://doi.org/10.1097/QAD.0000000000003923
- A 2-Year, Randomized, Clinical Trial Examining the Effects of Speed of Processing Cognitive Training on Quality-of-Life Indicators in Adults With HIV-Associated Neurocognitive Disorder in Birmingham, Alabama: Results of the Think Fast Study, Journal of the Association of Nurses in AIDS Care, 35, 2, (104-121), (2024).https://doi.org/10.1097/JNC.0000000000000449
- See more
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.